Company Name, Ticker, Customers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
ORMP's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Oramed Pharmaceuticals Inc News
Oramed Pharmaceuticals Inc's Effective Tax Rate
Oramed Pharmaceuticals Inc's Income per Employee
Oramed Pharmaceuticals Inc Business Description
Oramed Pharmaceuticals Inc Executive Officers
Economic Indicators
Fundamentals
Oramed Pharmaceuticals Inc Growth Rates
Oramed Pharmaceuticals Inc Profitability
Oramed Pharmaceuticals Inc Valuation
Oramed Pharmaceuticals Inc Management Effectiveness
Oramed Pharmaceuticals Inc Financial Strength
Oramed Pharmaceuticals Inc Efficiency
Oramed Pharmaceuticals Inc Dividend
Financials
Oramed Pharmaceuticals Inc Business Segments
Oramed Pharmaceuticals Inc Income Statement
Oramed Pharmaceuticals Inc Balance Sheets
Oramed Pharmaceuticals Inc Cash Flow Statement
Oramed Pharmaceuticals Inc Geographic Information
Suppliers
Oramed Pharmaceuticals Inc Suppliers Performance
ORMP Suppliers Stock Performance
ORMP Suppliers Growth Rates
ORMP Suppliers Data
ORMP Suppliers Efficiency
ORMP Suppliers Management Effectiveness
ORMP Suppliers Valuation
ORMP Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Oramed Pharmaceuticals Inc Market Share
Oramed Pharmaceuticals Inc Competition Performance
Oramed Pharmaceuticals Inc Competitors Results
ORMP Competitors Stock Performance
ORMP Competitors Growth Rates
ORMP Workforce Efficiency at the Competitors
ORMP Competitors Efficiency
ORMP Competitors Management Effectiveness
ORMP Competitors Valuation
Customers & Markets
Oramed Pharmaceuticals Inc Customers Demand
ORMP Customers Expenditure Growth Rates
ORMP Customers Performance
ORMP Customers Stock Performance
ORMP Customers Growth Rates
ORMP Workforce Efficiency at the Customers
ORMP Customers Efficiency
ORMP Customers Management Effectiveness
ORMP Customers Valuation
ORMP Customers by Companys' Segments
Charts & Quotes
Oramed Pharmaceuticals Inc Comparison Charts
ORMP OHLC Charts
ORMP's Tehnical Upper Indicators
ORMP's Tehnical Lower Indicators
ORMP's Weekly Charts
ORMP's Monthly Charts
Oramed Pharmaceuticals Inc's Profile
Company Charts and Quotes
Oramed Pharmaceuticals Inc News
Oramed Pharmaceuticals Inc's Geographic Information
Oramed Pharmaceuticals Inc's Income Statement
Oramed Pharmaceuticals Inc's Balance Sheets
Oramed Pharmaceuticals Inc's Cash Flow Statement
Oramed Pharmaceuticals Inc's Profitability
Oramed Pharmaceuticals Inc's Financials
Oramed Pharmaceuticals Inc's Net Margin
Oramed Pharmaceuticals Inc's Suppliers
Oramed Pharmaceuticals Inc's Competitors
Oramed Pharmaceuticals Inc's Markets & Customers
Oramed Pharmaceuticals Inc's Market Share
ORMP's Suppliers Performance
ORMP's Employee Efficiency at the Competitors
ORMP's Charts Money Flow
ORMP's Customers Demand
Economic Indicators
Net Margin by Industry
Efficiency Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
U.S. International Trade
News
Economy News
Stock News
Economy Terms
At a Glance
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Efficiency
Dividend Comparisons
Oramed Pharmaceuticals Inc
(
ORMP
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Cumulative Oramed Pharmaceuticals Inc 's Interest Coverage ratios
ORMP's Interest expense and Ebitda growth
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Interest Coverage▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Interest Coverage▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
ORMP Interest Coverage
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Interest expense Change
-
-
-
-
-
Y / Y Ebitda Change
-62.43 %
-87.27 %
-55.02 %
26.8 %
139.04 %
Interest Coverage (TTM)
19.79
-
-
-
-
Total Ranking
# 411
#
#
#
#
Seq. Interest expense Change
-
-
-
-
-
Seq. Ebitda Change
205.05 %
-62.58 %
-49.11 %
-35.32 %
3.39 %
New:
More ORMP's historic Interest Coverage Ratios >>
Financial strength information for the Major Pharmaceutical Preparations industry
>>
Back to ORMP Financial Strength Comparisons
>>
See ORMP Income statement
Interest Coverage in the third quarter 2023 Comment